IL180846A0 - 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors - Google Patents

1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Info

Publication number: IL180846A0
Authority: IL; Israel
Prior art keywords: hetero; heterocyclylethanes; arylethanes; tetra; tri
Prior art date: 2004-07-29

Application number

IL180846A

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-29

Filing date

2007-01-21

Publication date

2007-06-03

2007-01-21 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2007-06-03 Publication of IL180846A0 publication Critical patent/IL180846A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL180846A 2004-07-29 2007-01-21 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors IL180846A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US59218104P	2004-07-29	2004-07-29
PCT/US2005/026334 WO2006028590A1 (en)	2004-07-29	2005-07-25	1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Publications (1)

Publication Number	Publication Date
IL180846A0 true IL180846A0 (en)	2007-06-03

Family

ID=35613661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL180846A IL180846A0 (en)	2004-07-29	2007-01-21	1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors

Country Status (15)

Country	Link
KR (1)	KR20070043985A (en)
AR (1)	AR049847A1 (en)
BR (1)	BRPI0513793A (en)
CR (1)	CR8876A (en)
EC (1)	ECSP077208A (en)
IL (1)	IL180846A0 (en)
MA (1)	MA28980B1 (en)
MX (1)	MX2007001188A (en)
NO (1)	NO20071107L (en)
PE (1)	PE20060382A1 (en)
RU (1)	RU2344134C2 (en)
TW (1)	TW200607493A (en)
UA (1)	UA88018C2 (en)
WO (1)	WO2006028590A1 (en)
ZA (1)	ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102427806B (en) *	2009-03-18	2015-11-25	麦迪库瑞国际公司	Transdermal pharmaceutical formulation and administration of tirofiban
NZ703632A (en)	2012-06-11	2016-01-29	Bristol Myers Squibb Co	Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2140865B2 (en) *	1971-08-14	1979-10-11	Bayer Ag, 5090 Leverkusen	1-imidazolyl-methanephosphonic acid ester, process for their preparation and medicaments containing them
DE19951701A1 (en) *	1999-10-27	2001-05-03	Aventis Pharma Gmbh	Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions
ATE400551T1 (en) *	2002-01-04	2008-07-15	Neurosearch As	POTASSIUM CHANNEL MODULATORS

2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/en unknown
- 2005-07-22 TW TW094125011A patent/TW200607493A/en unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/en not_active Application Discontinuation
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/en not_active Withdrawn
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/en not_active IP Right Cessation
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en not_active Ceased
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/en unknown
- 2005-07-25 UA UAA200702125A patent/UA88018C2/en unknown
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/en not_active IP Right Cessation
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/en unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/en not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/en unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/en unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
MX2007001188A (en)	2007-03-21
BRPI0513793A (en)	2008-05-13
PE20060382A1 (en)	2006-05-15
ZA200700477B (en)	2009-08-26
RU2344134C2 (en)	2009-01-20
MA28980B1 (en)	2007-11-01
RU2007107408A (en)	2008-09-10
CR8876A (en)	2007-08-28
UA88018C2 (en)	2009-09-10
ECSP077208A (en)	2007-02-28
WO2006028590A1 (en)	2006-03-16
KR20070043985A (en)	2007-04-26
TW200607493A (en)	2006-03-01
NO20071107L (en)	2007-04-19
AR049847A1 (en)	2006-09-06

Similar Documents

Publication	Publication Date	Title
IL163928A0 (en)	2005-12-18	Pyridinoylpiperidines as 5-htf agonists
ZA200700351B (en)	2008-05-28	Compounds, compositions and methods
ZA200502210B (en)	2006-02-22	Substrates for O6-alkylguanine-DNA alkyltansferase.
IL183706A0 (en)	2007-09-20	2,4(4,6) pyrimidine derivatives
IL191711A0 (en)	2008-12-29	1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors
ZA200610142B (en)	2008-02-27	Furanopyrimidine compounds effective as potassium channel inhibitors
AP2321A (en)	2011-11-16	Quinoline derivatives for use as mycobactrial inhibitor.
EG25273A (en)	2011-12-04	Substituted dihydroquinazolines.
PL1725528T3 (en)	2013-12-31	Sulphonylpyrroles as hdac inhibitors
ZA200307420B (en)	2004-07-01	Point chisel.
EP1493437A4 (en)	2010-08-11	Compositions for diabetes
ZA200805028B (en)	2009-12-30	Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
AU2003212310A1 (en)	2003-10-13	(4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
ZA200704636B (en)	2008-09-25	2-alkyl-cycloalk(en)yl-carboxamides
WO2007062308A3 (en)	2007-10-04	Homo- and heterocyclic compounds suitable as cetp inhibitors
ZA201005087B (en)	2011-03-30	4-imidazolidinones as kv1.5 potassium channel inhibitors
IL180846A0 (en)	2007-06-03	1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors
ZA200810763B (en)	2009-09-30	Imidazolidinone Kv1.5 potassium channel inhibitors
ZA201005086B (en)	2011-03-30	4-imidazolidinones as kv1.5 potassium channel inhibitors
ITMI20032493A1 (en)	2005-06-18	HANDLING FOR AN ALTERNATIVE COMPRESSOR.
EP1723145A4 (en)	2009-12-02	Substituted 5,12-diaza-benzoanthracene analogues
TW576286U (en)	2004-02-11	Nail-absence non-percussion device for nailing gun
AU2003301258A1 (en)	2004-05-04	Calcium channel agonists for psychotherapeutic use
AU2823P (en)	2005-07-29	P000607 Plectranthus hilliardiae x (P. saccatus x P. hilliardiae)
HK1122294A (en)	2009-05-15	Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors